The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
Titel:
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study
Auteur:
Yıldırım, Hasan Çağrı Kutlu, Yasin Mutlu, Emel Aykan, Musa Barış Korkmaz, Mustafa Yalçın, Selim Şakalar, Teoman Celayir, Özde Melisa Kayıkçıoğlu, Erkan Aslan, Ferit Hafızoğlu, Emre Altıntaş, Yunus Emre Keskinkılıç, Merve Chalabiyev, Elvin Çelebi, Abdussamet Dursun, Bengü Kapar, Caner Özen, Miraç Acar, Ömer Dülgar, Özgecan Kut, Engin Biter, Sedat Kus, Fatih Almuradova, Elvina Erdoğan, Atike Pınar Saray, Seray Güven, Deniz Can Şimşek, Eda Tanrıkulu Üskent, Necdet Kemal, Yasemin Çakar, Burcu Açıkgöz, Özgür Kılıçkap, Saadettin Aksoy, Sercan